The effect of education based on the family-centered empowerment model on anticoagulant adherence of patients with prosthetic heart valve.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015100624395N1

Enrollment

Registered

2015-12-30

Start date

2015-08-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Valvular heart disease. Endocarditis and Heart valve Disorders in Diseases Classified Elsewhere

Interventions

Intervention 1: The education will be implemented based on the family-centered empowerment model steps as follows: 1- the first step is to increase the participants’ perceived threat (severity and sus

Prevention

Treatment - Drugs

The education will be implemented based on the family-centered empowerment model steps as follows: 1- the first step is to increase the participants’ perceived threat (severity and susceptibility). Th

In the control group will be provided to patients and family members one training session 60-45 minutes in discharge day.

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Willingness to participate in the study ; The age range of 65- 18 years; living in Mashhad; Artificial valve replacement surgery;The first shift valve replacement surgery; Failure to develop an advanced chronic disease (stroke, kidney failure) and lack cognitive and mental disorders (Alzheimer's, depression); Loss of speech and hearing problems; Having read and write; The patient has no health personnel; A family member (spouse, child, sister, etc.) that further cooperation in the field of health -care and the patient is Family members living with the patient; Lack of family members to valve disease Inclusion criteria 10,11 and 12 will be considered for patients in the intervention group. Inclusion criteria of active member of the family: willingness to participate in research; having read and write; lack of drug addiction; without the risk of heart valve disease; Is not of Health care worker Exclusion criteria: unwillingness of research or a member of his family to cooperate at every stage of research; hospitalization for any reason at any stage of research; changes in the anticoagulant medication; The incidence of postoperative complications requiring surgery, physical or mental problems that lead to disability at any stage of the research.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Adherence to anticoagulant treatment regimen. Timepoint: one and half month after intervention. Method of measurement: Questionnaire of Adherence to anticoagulant treatment regimen.	—

Secondary

Measure	Time frame
Bleeding. Timepoint: Three months after intervention. Method of measurement: Landfield questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Mohammadpour Ostad

Mashhad University of Medical Sciences

mohammadpoorm2@mums.ac.ir+98 51 3859 1511

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026